Bayer is deepening its involvement in CRISPR with a licensing agreement for genome editing patents. Irish partner ERS Genomics holds the rights to the CRISPR/Cas9 tech from Emmanuelle Charpentier, one of the inventors.
17
May
Siemens bags Molecular Dx firm
Newly rebranded Siemens Healthcare has entered the field of molecular testing for cancers with the acquisition of Cologne-based NEO New Oncology.
14
May
Aston Business School invests in the best: MBA Scholarships of up to £10,000
Aston Business School invests in the best with scholarships of up to £10,000 for MBA applicants
13
May